Get startedLog in
    Picture of Larimar Therapeutics logo

    LRMR — Larimar Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Larimar Therapeutics Announces FDA Breakthrough Therapy Designation For Nomlabofusp

    Picture of Larimar Therapeutics logoLarimar Therapeutics
    24/02/2026 12:12
    Feb 24 (Reuters) - Larimar Therapeutics Inc LRMR.O:

LARIMAR THERAPEUTICS ANNOUNCES FDA BREAKTHROUGH THERAPY DESIGNATION FOR NOMLABOFUSP IN FA AND REITERATES PLANNED BLA SUBMISSION IN JUNE 2026

Source text: ID:nGNX58Lvm5

Further company coverage: LRMR.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Larimar Therapeutics

    See all news